Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
How Does The Market Size Of The Respiratory Devices And Equipment (Therapeutic And Diagnostic) Industry Compare Between 2025 And 2029?
Market valuation for respiratory apparatus and instrumentation, encompassing both treatment and diagnostic tools, has expanded swiftly throughout the recent history, projecting a climb from a figure of $12.08 billion in the year 2024 to $13.62 billion across 2025, which translates to an annualized growth trajectory of 12.7 percent. This past expansion trend can be linked directly to several underlying causes, notably the increasing frequency of respiratory ailments, the demographic shift toward an older populace, environmental contamination and related external influences, alongside the wider adoption of remote patient care and continuous observational technologies.
Anticipated for swift expansion, the market encompassing respiratory apparatus and instrumentation, both for treatment and diagnosis, is projected to reach a substantial valuation of $23.65 billion by the year 2029, driven by an impressive compound annual growth rate (CAGR) of 14.8% throughout this projection timeframe, with key contributors to this upward trajectory being the advancement of less invasive procedures, expansion within developing economies, favorable regulatory frameworks and insurance coverage, alongside the increasing adoption of bespoke medical treatments, while prominent shifts shaping this sector involve a greater emphasis on care delivered in domestic settings, the proliferation of devices for continuous and remote patient surveillance, the incorporation of virtual healthcare solutions, and a growing commitment to environmentally conscious and sustainable operational methodologies.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2404&type=smp
What Are The Main Drivers Boosting The Respiratory Devices And Equipment (Therapeutic And Diagnostic) Industry’s Expansion?
The worldwide market for respiratory therapeutic apparatus and machinery is poised for expansion, fundamentally spurred by the rising incidence of conditions like asthma, Chronic Obstructive Pulmonary Disease (COPD), and pulmonary malignancies. Elevated rates of tobacco usage, a growing elderly demographic, exposure to airborne contaminants, and various allergens contribute to a heightened frequency of respiratory ailments, thereby fueling the international market for these therapeutic devices. Information from the World Health Organization indicates that tobacco consumption is responsible for four point nine million fatalities globally, with smoking directly implicated in one million annual deaths from COPD, one point seven million annual deaths from cardiovascular and respiratory illnesses combined, and zero point eight five million annual lung cancer deaths. Furthermore, an assessment published in an Italian periodical suggests that COPD affects approximately ten percent of individuals aged seventy-five and above within the United States. Data collected by Asthma UK highlights that five point four million residents in the United Kingdom are presently undergoing care for asthma, encompassing one point one million youngsters and four point three million adults.
What Are The Different Segment Classifications Within The Respiratory Devices And Equipment (Therapeutic And Diagnostic) Market?
The respiratory devices and equipment (therapeutic and diagnostic)market covered in this report is segmented –
1) By Type: Diagnostic devices, Therapeutic devices, Monitoring devices
2) By Application: Chronic Obstructive Pulmonary Disease (COPD), Asthma, Obstructive Sleep Apnea (OSA), Respiratory Distress Syndrome (RDS), Cystic Fibrosis, Pneumonia
3) By End User: Hospitals, Clinics, Homecare settings, Ambulatory service centers
Subsegments:
1) By Diagnostic Devices: Spirometers, Pulse Oximeters, Arterial Blood Gas (ABG) Analyzers, Capnometers, Peak Flow Meters
2) By Therapeutic Devices: Nebulizers, Inhalers (Metered-Dose Inhalers, Dry Powder Inhalers), Positive Airway Pressure (PAP) Devices, Oxygen Concentrators, Ventilators
3) By Monitoring Devices: Respiratory Rate Monitors, Blood Oxygen Saturation Monitors, Capnography Monitors, Pulmonary Function Monitors
Which Ongoing Trends Are Expected To Shape The Respiratory Devices And Equipment (Therapeutic And Diagnostic) Market Outlook?
Within the sector for respiratory apparatus and machinery, a growing trend sees firms channeling resources toward superior mechanical ventilators for optimizing patient care protocols. These sophisticated mechanical ventilators leverage artificial intelligence capabilities to elevate patient oversight by scrutinizing, interpreting, merging, and implementing information gathered from diverse and substantial data repositories. Such AI-integrated apparatus ensure uniform quality of care irrespective of specialist staff availability, refine therapeutic outcomes for individuals, mitigate occurrences of clinical error, and forecast the necessity for extended mechanical breathing support through the application of advanced AI methodologies. Key players in the provision of these smart mechanical ventilators include entities such as Hamilton Medical AG, Koninklijke Philips N.V., alongside several other significant industry contributors.
Which Leading Companies Dominate The Respiratory Devices And Equipment (Therapeutic And Diagnostic) Market Share?
Major companies operating in the respiratory devices and equipment (therapeutic and diagnostic) market include Smiths Medical Inc., Philips Healthcare, GE Healthcare, Chart Industries Inc., Invacare Corporation, Fisher & Paykel Healthcare Limited, ResMed Inc., Koninklijke Philips N.V., Dragerwerk AG, Medtronic plc, Masimo Corp., CareFusion Corporation, Compumedics Limited, Becton Dickinson and Company, Hamilton Medical, Mindray Medical International Limited, Vyaire Medical Inc., Getinge AB, AirSep Corporation, Breas Medical AB, Hill-Rom Holdings Inc., Inogen, Shenzhen Mindray Bio-Medical Electronics Co., Linde plc, DeVilbiss Healthcare LLC, Nihon Kohden Corporation, Nonin Medical Inc., O2 Concepts LLC, Precision Medical Inc., Pulmodyne Inc., Salter Labs Inc., Sechrist Industries Inc., Teleflex Inc., Ventec Life Systems, VitalAire, Weinmann Emergency Medical Technology GmbH + Co. KG, ZOLL Medical Corporation
Download The Full Report For Exclusive Market Findings:
How Do Regional Market Performances Compare Within The Respiratory Devices And Equipment (Therapeutic And Diagnostic) Industry?
Asia-Pacific was the largest region in respiratory devices and equipment (therapeutic and diagnostic) market in 2024. Western Europe was the second-largest region in respiratory devices and equipment (therapeutic and diagnostic) market. The regions covered in the respiratory devices and equipment (therapeutic and diagnostic) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
Request A Customized Version Of The Respiratory Devices And Equipment (Therapeutic And Diagnostic) Market Report:
https://www.thebusinessresearchcompany.com/customise?id=2404&type=smp
Browse Through More Reports Similar to the Global Respiratory Devices And Equipment (Therapeutic And Diagnostic) Market 2025, By The Business Research Company
Respiratory Devices And Equipment Therapeutic Global Market Report 2025
Respiratory Monitoring Devices Global Market Report 2025
Respiratory Devices And Equipment Global Market Report 2025
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model